1-6 of 6
Jon Travers
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract P079: The impact of BCL2 expression on sensitivity to the novel Aurora kinase B inhibitor AZD2811 in small cell lung cancer

Azusa Tanimoto, Carminia M. Della Corte, Kavya Ramkumar, Robert J. Cardnell, Allison C. Stewart, Carl M. Gay, Lauren Averett Byers, Qi Wang, Li Shen, Jing Wang, Jon Travers
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2021) 20 (12_Supplement): P079.
https://doi.org/10.1158/1535-7163.TARG-21-P079
Published: 01 December 2021
View article titled, Abstract P079: The impact of BCL2 expression on sensitivity to the novel Aurora kinase B inhibitor AZD2811 in small cell lung cancer
Journal Articles

Recombinant Newcastle Disease Virus Immunotherapy Drives Oncolytic Effects and Durable Systemic Antitumor Immunity

James Harper, Shannon Burke, Jon Travers, Nicola Rath, Andrew Leinster, Christel Navarro, Ruth Franks, Rebecca Leyland, Kathy Mulgrew, Kelly McGlinchey, Lee Brown, Simon J. Dovedi, Jens-Oliver Koopmann, Nicholas M. Durham, Xing Cheng, Hong Jin, Jim Eyles, Robert W. Wilkinson, Danielle Carroll
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2021) 20 (9): 1723–1734.
https://doi.org/10.1158/1535-7163.MCT-20-0902
Published: 01 September 2021
View article titled, Recombinant Newcastle Disease Virus Immunotherapy Drives Oncolytic Effects and Durable Systemic Antitumor Immunity
Open the PDF for Recombinant Newcastle Disease Virus Immunotherapy Drives Oncolytic Effects and Durable Systemic Antitumor Immunity in another window
Journal Articles

TSR-033, a Novel Therapeutic Antibody Targeting LAG-3, Enhances T-Cell Function and the Activity of PD-1 Blockade In Vitro and In Vivo

Srimoyee Ghosh, Geeta Sharma, Jon Travers, Sujatha Kumar, Justin Choi, H. Toni Jun, Marilyn Kehry, Sridhar Ramaswamy, David Jenkins
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (3): 632–641.
https://doi.org/10.1158/1535-7163.MCT-18-0836
Published: 01 March 2019
View article titled, TSR-033, a Novel Therapeutic Antibody Targeting LAG-3, Enhances T-Cell Function and the Activity of PD-1 Blockade <em>In Vitro</em> and <em>In Vivo</em>
Open the PDF for TSR-033, a Novel Therapeutic Antibody Targeting LAG-3, Enhances T-Cell Function and the Activity of PD-1 Blockade <em>In Vitro</em> and <em>In Vivo</em> in another window
Includes: Supplementary data
Journal Articles

Abstract A201: Discovery of TSR-033, a novel, potent anti-human LAG-3 therapeutic antibody

Srimoyee Ghosh, Haley Laken, Jon Travers, Sujatha Kamar, H. Toni Jun, Marilyn R. Kehry, David Jenkins
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2018) 17 (1_Supplement): A201.
https://doi.org/10.1158/1535-7163.TARG-17-A201
Published: 01 January 2018
View article titled, Abstract A201: Discovery of TSR-033, a novel, potent anti-human LAG-3 therapeutic antibody
Journal Articles

Preclinical anticancer properties of potent small molecule inhibitors of protein kinase D

Azadeh Bagherzadeh, Mark Charles, Stephen Jamieson, Jon Travers, Kevin Stewart, Maria Notaridou, Gregoire Pave, Julia Gilliatt, Fiona Smart, Matthew Trickett, Carmel Nanthakumar, Louise Bisset, Caroline Foxton, Tim Hammonds, Tony Raynham, Lloyd kelland
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (11_Supplement): A237.
Published: 01 November 2007
View article titled, Preclinical anticancer properties of potent small molecule inhibitors of protein kinase D
Journal Articles

High throughput screen for inhibitors of protein kinase C iota (PKCι)

Louise Bisset, Tim Hammonds, Jon Roffey, Lloyd Kelland, Jon Travers, Peter Parker, Svend Kjaer, Neil McDonald
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (11_Supplement): B253.
Published: 01 November 2007
View article titled, High throughput screen for inhibitors of protein kinase C iota (PKCι)